News

August 19, 2010 – The Cardiovascular Research Foundation recently announced the late-breaking trials and first report investigations being presented at the Transcatheter Cardiovascular...

August 3, 2010 — Patient enrollment began in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Boston Scientific Synergy Coronary Stent (previously referred...

July 30, 2010 – A drug-eluting coronary bifurcation stent received CE mark this week for clinical use in Europe. The Axxess Biolimus A9-Eluting Coronary Bifurcation Stent System uses a...

June 11, 2010 – A new drug-eluting stent (DES) was launched this week in the European Union and other CE mark countries. The Taxus Element Paclitaxel-Eluting Coronary Stent System is Boston...

June 3, 2010 – Six-month data from the first 45 patients enrolled in the second stage of a trial for a bioresorbable stent demonstrated strong results. Abbott's bioresorbable vascular scaffold (...

May 27, 2010 – One-year data presented this week at EuroPCR in Paris confirms sustained clinical outcomes with Cook Medical's drug-eluting peripheral stent, Zilver PTX.

May 26, 2010 – In the constantly evolving battle for the best coronary stent, Boston Scientific said today it initiated the PLATINUM PLUS clinical trial, comparing its next-generation Promus...

May 26, 2010 – The 12-month study results for a drug-eluting stent that uses hundreds of tiny holes, filled with bioresorbable drug polymer to reduce tissue/polymer contact, demonstrated excellent...

May 25, 2010 – The highly anticipated first results of the RESOLUTE All Comers study were presented today during the late-breaking clinical trial session of the 2010 EuroPCR meeting in Paris. In...

May 25, 2010 – A self-expanding, drug-eluting stent (DES) that just gained CE mark clearance in Europe is designed to ensure optimal apposition in the initial hours and days after an acute...

May 12, 2010 – A paclitaxel-eluting coronary stent received CE mark approval for a specific indication to treat diabetic patients. The Taxus Element incorporates a platinum chromium alloy and a...

May 10, 2010 – Patients treated with the Zilver PTX drug-eluting peripheral stent maintained clinical improvement at two years, according to interim results from the Zilver PTX Global Registry....

May 7, 2010 – Findings from the SPIRIT IV trial, one of the largest randomized clinical trials comparing two drug eluting stents with 3,690 U.S.-based patients, were published this week in The New...

May 6, 2010 – Patients who can postpone noncardiac surgery for at least six weeks after receiving a coronary stent are less likely to suffer reduced blood flow to the heart, heart attack and death...

May 6, 2010 – After entered the Japanese drug-eluting stent market earlier this year, Abbott's Xience V and Boston Scientific's Promus stents picked up share from competitors Medtronic and Cordis...

May 3, 2010 – Excellent safety and clinical outcomes were shown in patients ages 70 and older who received a stent using endothelial progenitor cell capture technology. The stent accelerates the...

April 21, 2010 — A landmark clinical trial has begun in Europe to explore the safety and efficacy of a paclitaxel-eluting stent for the treatment of renal artery disease.

April 21, 2010 – A stent that captures endothelial progenitor cells is now combined with thin cobalt chromium stent struts with a low profile for greater flexibility and deliverability. The Genous...

April 21, 2010 – More than 100,000 amputations are performed each year in the United States on patients with critical limb ischemia (CLI), the most severe form of peripheral arterial disease (PAD...

April 5, 2010 – Patient enrollment was recently completed in the Small Vessel and Long Lesion trials of the PLATINUM clinical program. It is designed to compare the platinum chromium Promus...